Literature DB >> 2434424

Vascular responsiveness to serotonin metabolites in mineralocorticoid hypertension.

L P Thompson, R C Webb.   

Abstract

This study characterizes vascular responsiveness to serotonin and its metabolites and to several monoamines that are structurally related to serotonin in deoxycorticosterone acetate (DOCA)-salt hypertension. Mesenteric arteries from normotensive and hypertensive rats were excised and cut into helical strips for isometric force recording. Dose-response curves to serotonin in arteries from hypertensive rats were shifted significantly to the left compared with those in arteries from normotensive rats (ED25: DOCA-treated = 2.4 X 10(-8) M; control = 17.1 X 10(-8) M). Contractile responses to 5-hydroxyindole acetic acid and 5-hydroxytryptophol were greater in mesenteric arteries from hypertensive rats, whereas reactivity to 5-methoxytryptamine and melatonin in arteries from hypertensive rats did not differ from that in arteries from normotensive rats. Mesenteric arteries from both rat groups were unresponsive to the serotonin metabolite N-acetylserotonin. Contractile responses to 5,6-dihydroxytryptamine and 6-hydroxytryptamine were greater in mesenteric arteries from hypertensive rats, whereas responsiveness to 3-hydroxytryptamine in hypertensive arteries did not differ from normotensive values. Contractile responses to serotonin and its metabolites and to the structurally related monoamines were inhibited by the serotonergic antagonist ketanserin. These results demonstrate that vascular sensitivity to serotonin is increased in DOCA-hypertensive rats. Based on the experiments with serotonin metabolites and with other monoamines, the increased responsiveness to these compounds appears to be related to the structural location of hydroxyl and amine moieties.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2434424     DOI: 10.1161/01.hyp.9.3.277

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  RhoA/Rho-kinase, vascular changes, and hypertension.

Authors:  K Chitaley; D Weber; R C Webb
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 2.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

3.  Mitochondrial monoamine oxidase-A-mediated hydrogen peroxide generation enhances 5-hydroxytryptamine-induced contraction of rat basilar artery.

Authors:  Christina Chui Wa Poon; Sai Wang Seto; Alice Lai Shan Au; Qian Zhang; Rachel Wai Sum Li; Wayne Yuk Wai Lee; George Pak Heng Leung; Siu Kai Kong; John Hok Keung Yeung; Sai Ming Ngai; Ho Pui Ho; Simon Ming Yuen Lee; Shun Wan Chan; Yiu Wa Kwan
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 4.  5-hydroxtryptamine receptors in systemic hypertension: an arterial focus.

Authors:  Stephanie W Watts; Robert Patrick Davis
Journal:  Cardiovasc Ther       Date:  2011-02       Impact factor: 3.023

Review 5.  Oh, the places you'll go! My many colored serotonin (apologies to Dr. Seuss).

Authors:  Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-23       Impact factor: 4.733

6.  One-month serotonin infusion results in a prolonged fall in blood pressure in the deoxycorticosterone acetate (DOCA) salt hypertensive rat.

Authors:  Robert Patrick Davis; Theodora Szasz; Hannah Garver; Robert Burnett; Nathan R Tykocki; Stephanie W Watts
Journal:  ACS Chem Neurosci       Date:  2012-09-16       Impact factor: 4.418

Review 7.  A review of deoxycorticosterone acetate-salt hypertension and its relevance for cardiovascular physiotherapy research.

Authors:  Lim-Kyu Lee; Mee-Young Kim; Ju-Hyun Kim; Jeong-Uk Lee; Byoung-Sun Park; Seung-Min Yang; Hye-Joo Jeon; Won-Deok Lee; Ji-Woong Noh; Taek-Yong Kwak; Tae-Hyun Lee; Ju-Young Kim; Hye-Young Kim; Byong-Yong Hwang; Bokyung Kim; Junghwan Kim
Journal:  J Phys Ther Sci       Date:  2015-01-09

8.  Untargeted serum metabolomics and tryptophan metabolism profiling in type 2 diabetic patients with diabetic glomerulopathy.

Authors:  Fanliang Zhang; Ruixue Guo; Wen Cui; Li Wang; Jing Xiao; Jin Shang; Zhanzheng Zhao
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.